Civic Intelligence

The Naspghan Foundation

990 • Fiscal year 2022 • EIN 76-0585072

Jan 01, 2022 to Dec 31, 2022 • Filed on Nov 15, 2023

Organization ProfileWWW.NASPGHAN.ORG/CONTENT/84/EN/FOUNDATION/ABOUT
714 N Bethlehem Pike 300Ambler, PA 19002

(215) 641-9800

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

61st percentile

0.21x

Higher debt load relative to assets than 61% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2022

Liabilities / Revenue

79th percentile

0.72x

Higher debt load relative to revenue than 79% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2022

Net Margin

75th percentile

24%

Higher net margin than 75% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2022

Top Officer Pay

84th percentile

$247,035

Higher top officer pay than 84% of similar nonprofits.

Top officer pay equals 12.4% of source-year revenue.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2022

Asset Growth

54th percentile

2.4%

Faster asset growth than 54% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2021 to 2022

Revenue Growth

53rd percentile

6.1%

Faster revenue growth than 53% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2021 to 2022

Balance Sheet
Liabilities / Assets61st percentile

Assets

Up

$6,677,645

Up $154,865 (+2.4%) from 2021

Net Assets

Down

$5,245,956

Down $76,390 (-1.4%) from 2021

Liabilities

Up

$1,431,689

Up $231,255 (+19%) from 2021

Revenue And Expenses
Liabilities / Revenue79th percentileNet Margin75th percentile

Revenue

Up

$1,995,391

Up $114,754 (+6.1%) from 2021

Expenses

Up

$1,511,688

Up $276,145 (+22%) from 2021

Net Income

Down

$483,703

Down $161,391 (-25%) from 2021

Historical Trend

Balance Sheet Trend

Asset Growth54th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$10M$5.0M$0Assets 2010: $4,217,937Liabilities 2010: $1,304,144Net Assets 2010: $2,913,7932010Assets 2011: $3,872,828Liabilities 2011: $993,448Net Assets 2011: $2,879,3802011Assets 2012: $4,314,002Liabilities 2012: $1,417,338Net Assets 2012: $2,896,6642012Assets 2013: $4,067,332Liabilities 2013: $988,862Net Assets 2013: $3,078,4702013Assets 2014: $4,108,702Liabilities 2014: $954,786Net Assets 2014: $3,153,9162014Assets 2015: $4,293,861Liabilities 2015: $1,186,791Net Assets 2015: $3,107,0702015Assets 2016: $4,561,907Liabilities 2016: $1,235,592Net Assets 2016: $3,326,3152016Assets 2017: $4,421,521Liabilities 2017: $1,013,676Net Assets 2017: $3,407,8452017Assets 2018: $4,502,389Liabilities 2018: $1,237,472Net Assets 2018: $3,264,9172018Assets 2019: $4,869,576Liabilities 2019: $950,580Net Assets 2019: $3,918,9962019Assets 2020: $5,610,869Liabilities 2020: $1,052,211Net Assets 2020: $4,558,6582020Assets 2021: $6,522,780Liabilities 2021: $1,200,434Net Assets 2021: $5,322,3462021Assets 2022: $6,677,645Liabilities 2022: $1,431,689Net Assets 2022: $5,245,9562022Assets 2023: $7,458,927Liabilities 2023: $1,785,821Net Assets 2023: $5,673,1062023Assets 2024: $8,213,426Liabilities 2024: $1,756,363Net Assets 2024: $6,457,0632024

Highlighted filing

2022

Assets$6,677,645
Liabilities$1,431,689
Net Assets$5,245,956
Open 2022 Filing

Operations Trend

Revenue Growth53rd percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$3.0M$2.0M$1.0M$0-$1.0MExpenses 2010: $1,529,0712010Revenue 2011: $1,107,751Expenses 2011: $1,112,855Net Income 2011: -$5,1042011Expenses 2012: $1,239,4352012Revenue 2013: $1,384,722Expenses 2013: $1,250,314Net Income 2013: $134,4082013Revenue 2014: $1,408,074Expenses 2014: $1,310,503Net Income 2014: $97,5712014Revenue 2015: $1,196,576Expenses 2015: $1,104,860Net Income 2015: $91,7162015Revenue 2016: $1,469,708Expenses 2016: $1,321,081Net Income 2016: $148,6272016Revenue 2017: $1,069,272Expenses 2017: $1,183,802Net Income 2017: -$114,5302017Revenue 2018: $1,261,701Expenses 2018: $1,178,150Net Income 2018: $83,5512018Revenue 2019: $1,594,603Expenses 2019: $1,307,252Net Income 2019: $287,3512019Revenue 2020: $1,544,768Expenses 2020: $1,085,923Net Income 2020: $458,8452020Revenue 2021: $1,880,637Expenses 2021: $1,235,543Net Income 2021: $645,0942021Revenue 2022: $1,995,391Expenses 2022: $1,511,688Net Income 2022: $483,7032022Revenue 2023: $1,825,546Expenses 2023: $1,721,379Net Income 2023: $104,1672023Revenue 2024: $2,269,887Expenses 2024: $1,855,146Net Income 2024: $414,7412024

Highlighted filing

2022

Revenue$1,995,391
Expenses$1,511,688
Net Income$483,703
Open 2022 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2022 to Dec 31, 2022
Signed
Nov 15, 2023
Return Version
2022v5.0
Gross Receipts
$2,422,979
Mission and Program Overview

Mission

See schedule o statement[1] to fund and promote research and educational programs that will advance the creation, application, and dissemination of knowledge of gastrointestinal, hepatobiliary, pancreatic and nutritional disorders in children.[2] to identify, encourage, support, and coordinate scientific research and professional study of these pediatric disorders.[3] to strengthen the role of pediatric gastrointestinal and nutritional scientists as leaders in research and education in these medical and health care fields.[4] to evaluate and improve the quality and availability of medical care for children with digestive disorders.[5] to support the research and educational programs of its parent organization (north american society for pediatric gastroenterology hepatology and nutrition inc.)

Funds & supports research and education missions of naspghan.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments in Publicly Traded Securities$4,152,521$3,976,291▼ $176,230
Cash and Non-Interest-Bearing Accounts$1,315,220$2,190,999▲ $875,779
Savings and Temporary Cash Investments$669,348$352,860▼ $316,488
Pledges and Grants Receivable$374,500$115,001▼ $259,499
Accounts Receivable-$29,738-
Prepaid Expenses and Deferred Charges$11,191$12,756▲ $1,565
Total Assets$6,522,780$6,677,645▲ $154,865
Liabilities
Grants Payable$1,095,000$1,286,000▲ $191,000
Accounts Payable and Accrued Expenses$95,434$95,689▲ $255
Deferred Revenue$10,000$50,000▲ $40,000
Total Liabilities$1,200,434$1,431,689▲ $231,255
Net Assets / Fund Balance
Net Assets With Donor Restrictions$3,608,924$3,160,869▼ $448,055
Net Assets Without Donor Restrictions$1,713,422$2,085,087▲ $371,665
Total Net Assets Fund Balance$5,322,346$5,245,956▼ $76,390
Total Liabilities and Net Assets / Fund Balance$6,522,780$6,677,645▲ $154,865

Endowment Activity

PeriodBeginningContrib.Gain/LossOther UsesEnd
2022$2,486,243-▼ $278,243-$2,058,214
2021$2,472,426-▲ $163,817-$2,486,243
2020$2,423,819-▲ $198,607-$2,472,426
2019$2,312,696-▲ $261,123-$2,423,819
2018$2,500,000-▼ $87,817-$2,312,696
Compensation and Service Providers
Top Officer Pay84th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Margaret StallingsExecutive DirectorPT$50,000$197,035$50,000

Board Members and Trustees

NameTitle
Barry Wershil MdPast President
Menno Verhave MdPast President
Ann Scheimann Md MbaPresident
Benjamin Gold MdDirector
Joel Rosh MdDirector
Karen Murray MdDirector
Marjorie MerrickDirector
Patricia Robuck Phd MphDirector
Praveen Goday MdDirector
Robert DahmsDirector
Vicky Ng MdDirector
Jeannie Huang Md MphSecretary-treasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$1,904,598
Program Service Revenue
$0
Investment Income
$90,793
Other Revenue
$0
All Other Contributions
$1,654,598
Change in Net Assets
$483,703

Audited Revenue Reconciliation

Revenue per Audited Statements
$1,995,391
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$-583,186
Total Revenue per Audited Statements
$1,412,205
Total Revenue per Form 990
$1,995,391
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$834,019
Other Expenses$589,673
Salaries, Compensation, and Employee Benefits$87,996
Total Fundraising Expense$27,220
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Individuals$819,019--$819,019
Comp Disqual Persons$32,955$11,365$5,680$50,000
Other Salaries and Wages$25,043$8,637$4,316$37,996
Fees for Services Other$7,679$13,393$14,201$35,273
Fees for Service Investment Mgmnt Fees-$23,093-$23,093
Occupancy$15,739$4,496$2,248$22,483
Grants to Domestic Orgs$15,000--$15,000
Insurance$2,271$648$324$3,243
Travel$1,879$536$268$2,683
Other Expenses$1,285$367$183$1,835
All Other Expenses-$1,091-$1,091
Total Functional Expenses$1,328,861$155,607$27,220$1,511,688

Audited Expense Reconciliation

Line ItemAmount
Total Expenses per Form 990$1,511,688
Expenses per Audited Statements$1,488,595
Total Expenses per Audited Statements$1,488,595
Expenses Not Reported on Financial Statements$23,093
Expenses Not Reported on Form 990$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
North American Soc for Pediatric Gastroenterology Hepatology & NutritionAmbler, PA501(c)(3)General Support$15,000
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“Governing body review of form 990 prior to its filing with the irs, a copy of the form 990 is reviewed by board of directors either electronically or at annual board meeting.”

Form 990, Part VI, Section B, Line 12C

“Monitoring and enforcement of conflicts policy all foundation officers and directors are required to complete a conflict of interest disclosure and update it on an annual basis via the "disclosure website". The conflict of interest subcommittee of naspghan, a related organization, made up of the chair of clinical care and quality, chair of ethics, and chair of professional development reviews all submitted disclosures. If a conflict exists, participation in board activity may be limited or prohibited.”

Form 990, Part VI, Section B, Line 15

“Compensation for the foundation's executive director is set by naspghan, a related organization. Compensation for the development director is determined and reviewed by the foundation board based on industry standards and performance evaluation and review.”

Form 990, Part VI, Section C, Line 19

“Public availability of other documents they are available upon request and for inspection at the organization's office.”

Filing and Contact Details

Filer

Filer Name
The Naspghan Foundation
EIN
76-0585072
Phone
2156419800
Address
714 N BETHLEHEM PIKE 300, AMBLER, PA 19002

Signing Officer

Name
Margaret Stallings
Title
Executive Director
Phone
2152330808
Signed
2023-11-15
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Menno Verhave
Formed
1988
Legal Domicile
TX
Voting Board Members
12
Independent Board Members
12
Employees
0
Volunteers
12

Preparer

Firm
Bbd Llp
Address
1835 MARKET STREET 3RD FLOOR, PHILADELPHIA, PA 19103
Preparer
Jennifer Solot
Phone
2155677770
Supplemental Narrative

Additional Explanations

SCHEDULE R, PART II, COLUMN B, NASPGHAN'S PRIMARY ACTIVITY:

“The mission of the north american society for pediatric gastroenterology, hepatology and nutrition is to advance the understanding of normal development, physiology and pathophysiology of diseases of the gastrointestinal tract and liver in children, improve quality of care by fostering the dissemination of this knowledge through scientific meetings, professional and public education, and policy development, and serve as an effective voice for members and the profession.”

Financial Statement Notes

PART V, LINE 4:

“Intended use of the endowment funds it consists of two endowments, both were received from pharmaceutical companies. The investment income for each endowment fund is restricted for the following purposes: [1]the investment income from $1,500,000 is restricted for innovative research awards. [2]the investment income from $1,000,000 is restricted for research grants in acid-peptic disorders.”

PART X, LINE 2:

“Uncertain tax positions under asc 740 gaap requires entities to evaluate, measure, recognize and disclose any uncertain income tax positions taken on their tax returns. Gaap prescribes a minimum recognition threshold that a tax position is required to meet in order to be recognized in the financial statements. The foundation believes that it had no uncertain tax positions as defined in gaap.”

PART XI, LINE 2D - OTHER ADJUSTMENTS:

“Investment expenses -23,093.”

Raw XML AppendixShowing 400 of 616 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt095434
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt095689
IRS990/AccountsReceivableGrp/EOYAmt029738
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0FUNDS & SUPPORTS RESEARCH AND EDUCATION MISSIONS OF NASPGHAN.
IRS990/AllOtherContributionsAmt01654598
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt01091
IRS990/AllOtherExpensesGrp/TotalAmt01091
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0EXECUTIVE DIRECTOR
IRS990/BooksInCareOfDetail/PhoneNum02152330808
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0714 N BETHLEHEM PIKE STE 300
IRS990/BooksInCareOfDetail/USAddress/CityNm0AMBLER
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0PA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd019002
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt01315220
IRS990/CashNonInterestBearingGrp/EOYAmt02190999
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompDisqualPersonsGrp/FundraisingAmt05680
IRS990/CompDisqualPersonsGrp/ManagementAndGeneralAmt011365
IRS990/CompDisqualPersonsGrp/ProgramServicesAmt032955
IRS990/CompDisqualPersonsGrp/TotalAmt050000
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01904598
IRS990/CYGrantsAndSimilarPaidAmt0834019
IRS990/CYInvestmentIncomeAmt090793
IRS990/CYOtherExpensesAmt0589673
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0483703
IRS990/CYSalariesCompEmpBnftPaidAmt087996
IRS990/CYTotalExpensesAmt01511688
IRS990/CYTotalFundraisingExpenseAmt027220
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt01995391
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DeferredRevenueGrp/BOYAmt010000
IRS990/DeferredRevenueGrp/EOYAmt050000
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0GRANTS AND AWARDS:[1] NASPGHAN/NASPGHAN FOUNDATION GEORGE FERRY YOUNG INVESTIGATORDEVELOPMENT AWARD:- THIS TWO-YEAR GRANT IS AVAILABLE TO JUNIOR FACULTY TO SUPPORTRESEARCH ACTIVITIES THAT HAVE THE POTENTIAL FOR EVOLUTION TO ANINDEPENDENT RESEARCH CAREER IN PEDIATRIC GASTROENTEROLOGY, HEPATOLOGYOR NUTRITION. MONIES ARE AWARDED IN SUPPORT OF A MERITORIOUS RESEARCHPROJECT IN THE CLINICAL OR BASIC SCIENCES TO STUDY THE DISEASES OF THEGASTROINTESTINAL TRACT, LIVER OR PANCREAS AND NUTRITIONAL DISORDERS INCHILDREN.SEE SCHEDULE O FOR CONTINUATIONS[2] NASPGHAN FOUNDATION/NESTLE NUTRITION RESEARCH YOUNG INVESTIGATORDEVELOPMENT AWARD:- THIS TWO-YEAR GRANT IS AVAILABLE TO JUNIOR FACULTY TO SUPPORTRESEARCH ACTIVITIES THAT HAVE THE POTENTIAL FOR EVOLUTION TO ANINDEPENDENT RESEARCH CAREER IN PEDIATRIC GASTROENTEROLOGY, HEPATOLOGYOR NUTRITION. THIS GRANT, GENEROUSLY SUPPORTED BY MEAD JOHNSON, IS AWARDED TO SUPPORT MERITORIOUS BASIC OR CLINICAL RESEARCH PROJECT RELATING TO NUTRITION IN INFANCY, CHILDHOOD OR ADOLESCENCE.[3] NASPGHAN FOUNDATION/TAKEDA PHARMACEUTICALS NORTH AMERICA INCRESEARCH INNOVATION AWARD:- THIS GRANT IS OFFERED IN ODD NUMBERED YEARS. THIS GRANT WILL PROVIDE$75,000 ANNUALLY FOR TWO YEARS (TOTAL $150,000) FOR INNOVATIVE,HIGH-IMPACT RESEARCH IN PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY ANDNUTRITION. THE INTENT OF THIS RESEARCH AWARD IS TO STIMULATESCIENTIFIC INQUIRY IN AN AREA THAT IS EXCEPTIONALLY INNOVATIVE AND HASTHE POTENTIAL TO IMPACT THE FIELD IN A HIGHLY NOVEL MANNER. APPLICANTSAT ANY CAREER LEVEL MAY APPLY.[4] NASPGHAN FOUNDATION/ASTRAZENECA RESEARCH IN PEPTIC ULCER DISEASES:- THIS GRANT WILL PROVIDE $75,000 ANNUALLY FOR TWO YEARS (TOTAL$150,000) FOR STUDIES FOCUSED ON THE EPIDEMIOLOGY, PATHOGENESIS,NATURAL HISTORY, GENETICS, DIAGNOSIS AND MANAGEMENT OF PEPTIC DISORDERSAND OTHER DISEASES OF THE UPPER GASTROINTESTINAL TRACT IN CHILDREN.DISEASES THAT ARE RELEVANT TO THIS ANNOUNCEMENT INCLUDE, BUT ARE NOTLIMITED TO GASTROESOPHAGEAL REFLUX, REFLUX ESOPHAGITIS, EOSINOPHILIC(ALLERGIC) ESOPHAGITIS, MOTILITY DISORDERS OF THE UPPERGASTROINTESTINAL TRACT, HELICOBACTER PYLORI INFECTION WITH OR WITHOUTULCERATION, NON-ULCER DYSPEPSIA, AND NON-BACTERIAL ULCER DISEASES.APPLICANTS AT ANY CAREER LEVEL MAY APPLY.[5] NASPGHAN FOUNDATION MID-LEVEL CAREER DEVELOPMENT AWARD - THISMID-LEVEL CAREER DEVELOPMENT AWARD IS FOR NASPGHAN MEMBERS PURSUINGRESEARCH IN PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION ANDARE AT A MID-LEVEL IN THEIR CAREER. MID-LEVEL IS DEFINED AS A FACULTYMEMBER WHO HAS HELD A FACULTY APPOINTMENT FOR AT LEAST 6 YEARS AT THETIME OF THE APPLICATION, BUT HAS NOT YET REACHED PROFESSOR LEVEL. THISAWARD WILL PROVIDE UP TO $100,000 IN DIRECT FUNDING FOR 2 YEARS($50,000 PER YEAR) FOR THE ADVANCEMENT OF RESEARCH CAREERS FORAPPLICANTS WITH SIGNIFICANT PROMISE IN THEIR MID-YEARS AS FACULTY. THEPROPOSAL MUST INCLUDE A FOCUSED AREA OF RESEARCH THAT WILL DIRECTLYENHANCE THE APPLICANT'S ABILITY TO ACHIEVE FURTHER NATIONALPEER-REVIEWED RESEARCH FUNDING AND RESULT IN SIGNIFICANT IMPACT ONGASTROINTESTINAL, NUTRITION AND LIVER HEALTH IN CHILDREN. BASIC,CLINICAL, TRANSLATIONAL, EPIDEMIOLOGIC, DISSEMINATION ANDIMPLEMENTATION RESEARCH ARE ALL ENCOURAGED. THIS AWARD IS TO FOSTEREITHER A NEW AREA OF ENQUIRY OR TO PROVIDE PILOT DATA IN AN ONGOINGAREA OF RESEARCH WITH SUBSTANTIAL POTENTIAL FOR NEW FUNDING.[6] NASPGHAN FOUNDATION/APGNN SUSAN MOYER NURSING RESEARCH GRANT - THISONE-YEAR GRANT IS AVAILABLE TO PEDIATRIC GASTROENTEROLOGY, NUTRITIONAND HEPATOLOGY NURSES TO SUPPORT RESEARCH ACTIVITIES THAT HAVE THEPOTENTIAL TO ADVANCE NURSING CARE OF PATIENTS AND FAMILIES OF CHILDRENWITH GASTROINTESTINAL, HEPATOBILIARY, PANCREATIC OR NUTRITIONALDISORDERS. MONIES ARE AWARDED IN SUPPORT OF A MERITORIOUS RESEARCHPROJECTS TO STUDY THE NURSING CARE OF FAMILIES AND CHILDREN WITHPEDIATRIC GASTROINTESTINAL, HEPATOBILIARY, PANCREATIC OR NUTRITIONALDISORDERS.[7] NASPGHAN FOUNDATION/ABBOTT NUTRITION ADVANCED FELLOWSHIP TRAININGIN PEDIATRIC NUTRITION - THE AWARD I
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt03608924
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt03160869
IRS990/DonorRstrOrQuasiEndowmentsInd01
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0847820
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesOtherGrp/FundraisingAmt014201
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt013393
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt07679
IRS990/FeesForServicesOtherGrp/TotalAmt035273
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt023093
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt023093
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt03.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt10.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt237.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt30.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt40.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt50.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt60.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt70.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt80.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt90.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt100.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt110.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt126.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd10X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd11X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt110
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt123918
IRS990/Form990PartVIISectionAGrp/PersonNm0MENNO VERHAVE MD
IRS990/Form990PartVIISectionAGrp/PersonNm1BARRY WERSHIL MD
IRS990/Form990PartVIISectionAGrp/PersonNm2ANN SCHEIMANN MD MBA
IRS990/Form990PartVIISectionAGrp/PersonNm3PRAVEEN GODAY MD
IRS990/Form990PartVIISectionAGrp/PersonNm4BENJAMIN GOLD MD
IRS990/Form990PartVIISectionAGrp/PersonNm5JEANNIE HUANG MD MPH
IRS990/Form990PartVIISectionAGrp/PersonNm6MARJORIE MERRICK
IRS990/Form990PartVIISectionAGrp/PersonNm7KAREN MURRAY MD
IRS990/Form990PartVIISectionAGrp/PersonNm8VICKY NG MD
IRS990/Form990PartVIISectionAGrp/PersonNm9PATRICIA ROBUCK PHD MPH
IRS990/Form990PartVIISectionAGrp/PersonNm10JOEL ROSH MD
IRS990/Form990PartVIISectionAGrp/PersonNm11ROBERT DAHMS
IRS990/Form990PartVIISectionAGrp/PersonNm12MARGARET STALLINGS
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt1250000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt12193117
IRS990/Form990PartVIISectionAGrp/TitleTxt0PAST PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1PAST PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt2PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5SECRETARY-TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt10DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt11DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt12EXECUTIVE DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr01988
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolAndSepBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/SecuritiesAmt0-13870
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt012
IRS990/GrantAmt0834019
IRS990/GrantsPayableGrp/BOYAmt01095000
IRS990/GrantsPayableGrp/EOYAmt01286000
IRS990/GrantsToDomesticIndividualsGrp/ProgramServicesAmt0819019
IRS990/GrantsToDomesticIndividualsGrp/TotalAmt0819019
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt015000
IRS990/GrantsToDomesticOrgsGrp/TotalAmt015000
IRS990/GrantsToIndividualsInd01
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt0413718
IRS990/GrossReceiptsAmt02422979
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt012
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InsuranceGrp/FundraisingAmt0324
IRS990/InsuranceGrp/ManagementAndGeneralAmt0648
IRS990/InsuranceGrp/ProgramServicesAmt02271
IRS990/InsuranceGrp/TotalAmt03243
IRS990/InvestmentIncomeGrp/ExclusionAmt0104663
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0104663
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsPubTradedSecGrp/BOYAmt04152521
IRS990/InvestmentsPubTradedSecGrp/EOYAmt03976291
IRS990/IRPDocumentCnt010
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0TX
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt0427588
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembershipDuesAmt0250000
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0THE NASPGHAN FOUNDATION FUNDS AND SUPPORTS THE RESEARCH AND EDUCATION MISSIONS OF NASPGHAN IN ORDER TO ENHANCE THE HEALTH AND WELL-BEING OF CHILDREN WITH GASTROINTESTINAL, LIVER, PANCREAS AND NUTRITIONAL DISORDERS.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt05322346
IRS990/NetAssetsOrFundBalancesEOYAmt05245956
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0-13870
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0-13870
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt0-560093
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt01713422
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt02085087
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/FundraisingAmt02248
IRS990/OccupancyGrp/ManagementAndGeneralAmt04496
IRS990/OccupancyGrp/ProgramServicesAmt015739
IRS990/OccupancyGrp/TotalAmt022483
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherExpensesGrp/Desc0EDUCATION MATERIALS
IRS990/OtherExpensesGrp/Desc1MISCELLANEOUS EXPENSES
IRS990/OtherExpensesGrp/Desc2GRANT ADMINISTRATION
IRS990/OtherExpensesGrp/Desc3PRINTING
IRS990/OtherExpensesGrp/FundraisingAmt0183
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt091981
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt1367
IRS990/OtherExpensesGrp/ProgramServicesAmt0397430
IRS990/OtherExpensesGrp/ProgramServicesAmt110561
IRS990/OtherExpensesGrp/ProgramServicesAmt21285
IRS990/OtherExpensesGrp/TotalAmt0397430
IRS990/OtherExpensesGrp/TotalAmt191981
IRS990/OtherExpensesGrp/TotalAmt210561
IRS990/OtherExpensesGrp/TotalAmt31835
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt04316
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt08637
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt025043
IRS990/OtherSalariesAndWagesGrp/TotalAmt037996
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt0374500
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt0115001
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt011191
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt012756
IRS990/PrincipalOfficerNm0MENNO VERHAVE
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0EDUCATIONAL CAMPAIGNS:THE FOUNDATION SUPPORTS THE EDUCATIONAL MISSION OF NASPGHAN THROUGH ADIVERSE PORTFOLIO OF PROFESSIONAL AND PUBLIC EDUCATION INITIATIVES.TOPIC AREAS ARE REFLUX AND GERD, INFLAMMATORY BOWEL DISEASE, CELIACDISEASE AND GLUTEN-RELATED DISORDERS, CONSTIPATION, EOSINOPHILICESOPHAGITIS, NUTRITION, ENDOSCOPY, AND NONALCOHOLIC FATTY LIVER DISEASEIN CHILDREN, ADOLESCENTS AND YOUNG ADULTS. THE FOUNDATION'S GOAL IS TOEDUCATE MEDICAL PROFESSIONALS AND THE PUBLIC, AND TO SUPPORT THEDEVELOPMENT OF NEW RESEARCH IN THESE AREAS. THE PRIMARY OBJECTIVES ARETO IMPROVE THE QUALITY OF LIFE AND TO CHANGE PEDIATRIC AND ADULT HEALTHOUTCOMES BY EARLY DETECTION AND INTERVENTION.GIKIDS IS THE PATIENT OUTREACH AND EDUCATION EFFORT OF NASPGHAN. WITHGIKIDS, NASPGHAN AND THE FOUNDATION ARE WORKING TO REACH OUT DIRECTLYTO FAMILIES, KIDS AND TEENS WHO LIVE WITH DIGESTIVE CONDITIONS TOPROVIDE THEM WITH THE INFORMATION THEY NEED TO:-UNDERSTAND AND IMPROVE THEIR DIGESTIVE HEALTH-WORK WITH THEIR HEALTH CARE PROVIDERS-LIVE A MORE INDEPENDENT LIFE-UNDERSTAND WHAT WORKS IN PLAIN LANGUAGE"A PRACTICAL APPROACH TO NUTRITIONAL MANAGEMENT OF CHILDREN WITH CHOLESTATIC LIVER DISEASES: TIPS FOR PATIENTS AND CAREGIVERS" WEBINAR AND ON DEMAND PROGRAMCHILDREN WITH CHOLESTATIC LIVER DISEASES HAVE UNIQUE NUTRITIONAL REQUIREMENTS. OBJECTIVES: 1.OVERVIEW OF THE CLINICAL PRESENTATION AND LONG-TERM IMPLICATIONS OF MALNUTRITION AND FAT-SOLUBLE VITAMIN DEFICIENCIES IN CHILDREN WITH CHOLESTATIC LIVER DISORDERS.2.REVIEW CURRENT AVAILABLE FORMULATION AND PRACTICAL TIPS FOR THE CARE PROVIDER.3.REVIEW THE CURRENTLY AVAILABLE VITAMIN SUPPLEMENTS, FORMULATIONS AND DISCUSSION 4.DISCUSS LACK OF INSURANCE COVER FOR MEDICAL FOOD, VITAMINS AND FINANCIAL BURDEN TO THE FAMILIES.HEPATITIS C SLIDE SET AND GRAND ROUNDSHCV INFECTION IS CHILDREN IS FREQUENTLY UNRECOGNIZED. RECENTLY PROPOSED UNIVERSAL TESTING STRATEGIES DURING PREGNANCY NEED TO BE IMPLEMENTED. ALTHOUGH LIVER DISEASE IS GENERALLY MILD IN CHILDREN, CHRONIC HEPATITIS AND CIRRHOSIS OCCURS. DIRECT ACTIVE ANTIVIRALS ARE VERY EFFICACIOUS AND SAFE. THEREFORE, ALL HCV INFECTED CHILDREN > 3 YEARS OF AGE SHOULD BE CONSIDERED FOR TREATMENT. PUBLIC AND PROFESSIONAL EDUCATION IS CRITICALLY IMPORTANT TO INCREASE HCV AWARENESS. THE FOUNDATION DEVELOPED A SLIDE DECK AND GRAND ROUNDS PROGRAM TO INCREASE AWARENESS REGARDING TESTING AND MANAGEMENT OF HCV."NUTRITION AND LIVER DISEASE IN PEROXISOMAL BIOGENESIS DISORDERS: DIAGNOSIS AND MANAGEMENT" NASPGHAN NUTRITION UNIVERSITY (N2U)THIS COURSE IS DESIGNED TO PROVIDE SPECIALIZED NUTRITION EDUCATION INAREAS ASSOCIATED WITH THE PRACTICE OF PEDIATRIC GASTROENTEROLOGY ANDNUTRITION TO 3RD YEAR FELLOWS, JUNIOR FACULTY AND DIETITIANS. ITTARGETS TWO GROUPS: CANDIDATES WHO RECEIVED MINIMAL NUTRITION EDUCATIONDURING THEIR FELLOWSHIP OR WHOM PLAN TO PURSUE PEDIATRIC NUTRITION ASTHEIR CAREER FOCUS.TEACHING AND TOMORROW UNDERREPRESENTED IN MEDICINE (URIM) PROGRAMTHE PEDIATRIC GI TEACHING AND TOMORROW PROGRAM OF NASPGHAN STRIVES TO ATTRACT THE BRIGHTEST RESIDENTS TO SUBSPECIALTY TRAINING IN PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION. DUE TO THE EXCELLENT INTEREST IN THIS INNOVATIVE NASPGHAN PROGRAM, WE HAVE SEEN CONTINUAL GROWTH IN THE INTEREST AND APPLICATIONS TO GI TRAINING PROGRAMS THROUGH THE YEARS. THIS PROGRAM HAS BEEN RECENTLY EXPANDED TO PROVIDE SCHOLARSHIPS TO INTERESTED 1ST AND 2ND YEAR PEDIATRIC RESIDENTS AND 4TH YEAR MEDICAL STUDENTS WHO SELF-IDENTIFY AS UNDERREPRESENTED IN MEDICINE (URIM). IN ADDITION TO NETWORKING WITH OTHER PARTICIPANTS WHILE ATTENDING THE PROGRAM'S SCHEDULED SESSIONS, THE URIM PROGRAM ATTENDEES ARE MATCHED UP WITH A NASPGHAN FELLOW AND/OR ATTENDING PHYSICIAN (A TEACHING AND TOMORROW PROGRAM ALUMNUS) WHO SERVES AS A POINT OF CONTACT AND AMBASSADOR TO THE ANNUAL MEETING. WE WERE ABLE TO SUPPORT 5 STUDENTS IN 2022 AND 17 IN 2023.URIM NASPGHAN/NASPGHAN FOUNDATION MEDICAL STUDENT MENTORED SUMMER RESEARCH PROGRAMTHE URIM NASPGHAN/NASPGHAN FOUNDATION MEDICAL STUDENT MENT
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt0481041
IRS990/ProgSrvcAccomActy3Grp/Desc0WEBINARS AND ON-DEMAND EDUCATIONAL MODULESEGIDS: BEYOND THE ESOPHAGUSEGIDS ARE A COLLECTION OF CHRONIC INFLAMMATORY DISEASES INCLUDING EOSINOPHILIC ESOPHAGITIS (EOE), EOSINOPHILIC GASTRITIS (EG) EOSINOPHILIC GASTROENTERITIS (EGE), AND EOSINOPHILIC COLITIS (EC). AMONG THE EGIDS, EOE HAS BECOME AN INCREASINGLY RECOGNIZED AND STUDIED CONDITION. VALIDATED METRICS HAVE BEEN ESTABLISHED TO QUANTIFY QUALITY OF LIFE, SYMPTOMS, HISTOLOGIC AND ENDOSCOPIC FINDINGS. IN ADDITION, THERE ARE WELL-ESTABLISHED, EFFECTIVE TREATMENTS. THE SAME CANNOT BE SAID FOR EG, EGE, OR EC, WHICH LACKS WELL ESTABLISHED HISTOLOGIC CRITERIA FOR DIAGNOSIS, AND HAS A MORE UNCLEAR NATURAL HISTORY, NOR WELL-ESTABLISHED TREATMENTS. EGIDS: BEYOND THE ESOPHAGUS BRINGS TO LIGHT THE LATEST ON NON-EOE EGID, INCLUDING THE SIGNS AND SYMPTOMS; THE CRITERIA TO MAKE A DIAGNOSIS; WHAT OPTIONS EXIST FOR THERAPY, AND THE POTENTIAL MECHANISMS OF DISEASE. PRACTICAL TIPS IN THE NUTRITIONAL MANAGEMENT OF CHILDREN WITH CHOLESTATIC LIVER DISORDERS: A WEBINAR FOR PATIENTS, FAMILIES AND CAREGIVERSTHIS WEBINAR EXPLORES PRACTICAL APPROACHES TO THE NUTRITIONAL MANAGEMENT OF CHILDREN WITH CHOLESTATIC LIVER DISEASES, WITH SPECIAL TIPS FOR PATIENTS AND CAREGIVERS. PARTICIPANTS LEARN THE CLINICAL PRESENTATION AND LONG-TERM IMPLICATIONS OF MALNUTRITION AND FAT-SOLUBLE VITAMIN DEFICIENCIES IN CHILDREN WITH CHOLESTATIC LIVER DISORDERS, BECOME ACQUAINTED WITH DIFFERENCES AMONG THE CURRENTLY AVAILABLE FORMULATION TO SUPPORT NUTRITION IN CHOLESTATIC BABIES, AND THE CURRENTLY AVAILABLE VITAMIN SUPPLEMENTS AND FORMULATIONS. THE LACK OF INSURANCE COVERAGE FOR MEDICAL FOOD AND VITAMINS IS ALSO DISCUSSED.
IRS990/ProgSrvcAccomActyOtherGrp/Desc0CHILDREN WITH CHOLESTATIC LIVER DISEASE: DIAGNOSTICSCHOLESTATIC JAUNDICE IS A RARE PRESENTATION OF VARIOUS HEPATOBILIARY, METABOLIC, AND GENETIC DISORDERS. CHOLESTASIS TYPICALLY PRESENTS IN THE NEONATAL/INFANTILE PERIOD BUT CAN ALSO PRESENT LATE IN OLDER CHILDREN OR EVEN ADULTS. EARLY DIAGNOSIS AND APPROPRIATE MANAGEMENT OF THE UNDERLYING CONDITION ARE OF PARAMOUNT IMPORTANCE FOR OPTIMAL PROGNOSIS. DIAGNOSIS OF CHOLESTASIS NEEDS AN ARRAY OF INVESTIGATIONS INCLUDING BLOOD TESTS, IMAGING, GENETIC TESTING, AND INVASIVE PROCEDURES LIKE LIVER BIOPSY. LIVER BIOPSY IS ONE OF THE CENTRAL CRUCIAL INVESTIGATIONS DONE IN EVALUATING CHILDREN WITH CHOLESTASIS, HOWEVER, CAN BE ASSOCIATED WITH COMPLICATIONS INCLUDING BLEEDING. UNDERSTANDING WHEN TO USE A LIVER BIOPSY IN CHILDREN WITH CHOLESTASIS ALONG WITH ITS LIMITATIONS IS EXTREMELY IMPORTANT TO GAIN THE MAXIMUM BENEFIT OUT OF AN INVASIVE PROCEDURE. OVER THE LAST DECADE, THE GROWTH IN GENETIC TECHNIQUES AND THE IDENTIFICATION OF NEW GENES LEADING TO CHOLESTASIS IN CHILDREN HAVE EVOLVED SIGNIFICANTLY AND HAVE LED TO THE SHRINKING OF THE UNIDENTIFIED ETIOLOGIES. THIS WEBINAR ADDRESSES THE RAPIDLY EVOLVING FIELD OF GENETIC CHOLESTASIS AND WHEN TO PERFORM A LIVER BIOPSY, ITS UTILITY, AND LIMITATIONS. MEDICAL MANAGEMENT OF CHRONIC PANCREATITIS IN CHILDREN: MAXIMIZING TREATMENT AND IMPROVING OUTCOMESCHRONIC PANCREATITIS (CP) IN CHILDREN IS ASSOCIATED WITH SIGNIFICANT MORBIDITY AND POOR QUALITY OF LIFE. THE INCIDENCE OF CP IN CHILDREN HAS RISEN OVER THE PAST FEW DECADES AND IS APPROACHING THAT SEEN IN THE ADULT POPULATION. CP IS AN INFLAMMATORY DISEASE RESULTING IN IRREVERSIBLE CHANGES IN THE PANCREAS INCLUDING ACINAR CELL LOSS, FIBROSIS, DUCTAL CHANGES, AND CALCIFICATIONS. PATIENTS WITH CP MAY SUFFER FROM ABDOMINAL PAIN AND COMPLICATIONS OF EXOCRINE PANCREATIC INSUFFICIENCY (EPI) AND DIABETES MELLITUS. MEDICAL MANAGEMENT OF CHRONIC PANCREATITIS IN CHILDREN: MAXIMIZING TREATMENT AND IMPROVING OUTCOMES BRINGS TOGETHER LEADING EXPERTS TO DISCUSS HOW TO ENSURE THAT CHILDHOOD CP IS RECOGNIZED EARLY AND ITS SEQUALAE TREATED PROMPTLY.
IRS990/ProgSrvcAccomActyOtherGrp/Desc1REMOVING DIETING FROM DIET THERAPIES IN PEDIATRIC GIOBESITY WAS DECLARED AN EPIDEMIC BY THE CDC IN THE 1990S, YET SIGNIFICANT AND SUSTAINED WEIGHT LOSS CONTINUES TO BE PROBLEMATIC FOR AMERICANS AS A POPULATION. CRITICAL FACTORS ARE OFTEN OVERLOOKED WHEN ADDRESSING OBESITY SUCH AS RACIAL DISCRIMINATION, DISABILITY STATUS, AND ENVIRONMENTAL FACTORS. IN CONJUNCTION, "WEIGHT STIGMA", OR BIAS THAT DEVALUES PEOPLE WITH LARGER BODIES, CAN CAUSE INCREASED MORBIDITY AND MORTALITY, INDEPENDENT OF BMI. AS A RESPONSE, A MOVEMENT IS TAKING PLACE, KNOWN BY SEVERAL NAMES INCLUDING "ANTI-DIET OR "INTUITIVE EATING". THIS IS AN INCLUSIVE MOVEMENT THAT RECOGNIZES ONE'S SIZE AS PART OF HIS OR HER IDENTITY AS MUCH AS RACE, NATIONAL ORIGIN, AND SEXUALITY. IT CONSIDERS SOCIAL, ECONOMIC, AND PHYSICAL BARRIERS TO OBESITY, RATHER THAN ASSUMING LACK OF WILLPOWER OR EDUCATION ARE THE CAUSE. IT'S ABOUT RECOGNIZING "DIET CULTURE AND DISMANTLING THE ANTI-FAT AND PRO-THIN MESSAGES THAT INFILTRATE SOCIETY. THIS INFORMATIVE AND INTERACTIVE WEBINAR HELPS HEALTHCARE PROVIDERS RECOGNIZE WEIGHT STIGMA AND PROMOTE A POSITIVE RELATIONSHIP WITH FOOD, PARTICULARLY IN PATIENTS WITH GI-RELATED HEALTH CONDITIONS AND THOSE FOLLOWING THERAPEUTIC DIETS.
IRS990/ProgSrvcAccomActyOtherGrp/Desc2THE WHAT, HOW AND IFS OF OPTIMIZING EARLY CHILDHOOD GROWTH AND LONG-TERM OUTCOMES: PART ONEUNDERSTANDING NORMAL GROWTH AND DEVELOPMENT IS CRITICALLY ESSENTIAL FOR QUICK RECOGNITION AND INTERVENTION FOR DEVIATIONS IN CHILDHOOD GROWTH AND NUTRIENT INTAKE PRACTICES ASSOCIATED WITH INCREASED RISK FOR DISEASE AND POOR LONG-TERM HEALTH. NUTRIENT AND NON-NUTRIENT FACTORS INFLUENCE HEALTH OUTCOMES THROUGHOUT THE LIFECYCLE. THIS WEBINAR AND PODCAST SERIES, THE WHAT, HOW AND IFS OF OPTIMIZING EARLY CHILDHOOD GROWTH AND LONG-TERM OUTCOMES DISCUSSES HOW TO IMPLEMENT NUTRIENT AND NON-NUTRIENT FACTORS THAT OPTIMIZE LONG-TERM HEALTH, RECOGNIZE CHILDHOOD GROWTH AND NUTRIENT INTAKE PATTERNS ASSOCIATED WITH DISEASE, CHILDHOOD MICROBIOME AND LONG-TERM RISK FOR DISEASE, AND EARLY DIAGNOSIS AND MANAGEMENT STRATEGIES FOR CHILDHOOD FEEDING DISORDERS.THE WHAT, HOW AND IFS OF OPTIMIZING EARLY CHILDHOOD GROWTH AND LONG-TERM OUTCOMES: PART TWOUNDERSTANDING NORMAL CHILDHOOD GROWTH IS ESSENTIAL FOR QUICK RECOGNITION AND INTERVENTION FOR DEVIATIONS IN GROWTH AND NUTRIENT INTAKE ASSOCIATED WITH LONG-TERM RISK FOR DISEASE AND POOR HEALTH. THEREFORE, THE 'WHAT, HOW, AND IFS OF OPTIMIZING CHILDHOOD GROWTH AND LONG-TERM OUTCOMES' WEBINAR SERIES ADDRESSES THE KNOWLEDGE AND PRACTICE GAPS ABOUT NUTRIENT AND NON-NUTRIENT FACTORS ESSENTIAL FOR OPTIMIZING LONG-TERM HEALTH OUTCOMES. THE FIRST WEBINAR ADDRESSES THE EARLY LIFE NUTRITIONAL FACTORS THAT PROMOTE HEALTHY GROWTH, THE DEVELOPMENT OF A MICROBIOME ASSOCIATED WITH OPTIMIZED LONG-TERM HEALTH, AND THE RECOGNITION OF EARLY CHILDHOOD GROWTH PATTERNS RELATED TO LONG-TERM RISK FOR OVERWEIGHT AND OBESITY. THIS PART TWO WEBINAR FOCUSES ON A NUTRITIONAL ASSESSMENT APPROACH THAT QUICKLY RECOGNIZES DISEASE, NUTRITIONAL MANAGEMENT OF CHILDHOOD FEEDING DISORDERS, AND PRINCIPLES AND STRATEGIES FOR WEANING CHILDREN FROM DEPENDENCE ON TUBE FEEDS.CHILDREN WITH CHOLESTATIC LIVER DISEASE: PRURITIS MANAGEMENTPRURITUS IS A COMMON COMPLICATION OF CHOLESTATIC LIVER DISEASE THAT CAN SIGNIFICANTLY IMPAIR QUALITY OF LIFE. INTRACTABLE PRURITUS IS AN INDICATION FOR LIVER TRANSPLANT REGARDLESS OF PELD/MELD SCORE. THE PATHOPHYSIOLOGY OF PRURITUS IS COMPLEX. SEVERAL MEDICATIONS SERVE AS STANDARDS FOR TREATMENT AND RECENT ADVANCES IN QUANTIFICATION HAS ALLOWED FOR RIGOROUS AND CONTROLLED STUDY OF NEW MEDICATIONS. IN CERTAIN CIRCUMSTANCES, LIVER TRANSPLANT CAN BE AVOIDED OR DELAYED WITH SURGICAL BILIARY INTERVENTION.NASPGHAN FELLOWS TOOLBOX WEBSITETHE NASPGHAN TOOLBOX WEBSITE IS DESIGNED TO DELIVER PEDIATRIC GASTROENTEROLOGY INFORMATION TO CARE PROVIDERS IN A FORMAT THAT IS USER FRIENDLY. THE TOOLBOX PROVIDES EASY ACCESS TO CLINICAL GUIDELINES FOR PEDIATRIC GASTROENTEROLOGISTS AND TRAINEES AND IS NOW AVAILABLE AS A DISTINCT WEBSITE LINKED FROM THE NASPGHAN WEBSITE. FEATURES OF THE TOOLBOX INCLUDE ALGORITHMS TO NAVIGATE CLINICAL GUIDELINES FOR VARIOUS DISEASES; HIGH QUALITY IMAGES OF GI PATHOLOGY; HELPFUL TABLES ON MANAGING NUTRITIONAL NEEDS; SCORES AND CALCULATORS TO ASSIST IN CALCULATING IMPORTANT PEDIATRIC GI SCORES; AND A CONVENIENT SEARCH FEATURE.JUNIOR FACULTY CONFERENCE (DECEMBER 2022)NASPGHAN AND THE NASPGHAN ORGANIZED A STAND-ALONE CONFERENCE DEVOTED TO THE CAREER AND PROFESSIONAL DEVELOPMENT OF OUR MEMBERS AT A JUNIOR LEVEL IN THEIR PROFESSIONAL CAREER; I.E. 2 TO 7 YEARS OUT OF FELLOWSHIP TRAINING. THIS CONFERENCE ADDRESSES ONGOING PROFESSIONAL DEVELOPMENT FOR MEMBERS AT THE JUNIOR LEVEL OF THEIR CAREER, CONTINUE TO NURTURE AND AUGMENT EXISTING AND NEW PROFESSIONAL RELATIONSHIPS AND COLLABORATION, AND COVER SUCH TOPICS AS EXPANDING SELF-AWARENESS AND PERSONAL LEADERSHIP STYLES, IMPROVING COMMUNICATION, DIVERSITY AND INCLUSION, INCREASING FINANCIAL ACUMEN AND STRATEGIC PLANNING, NEGOTIATION STRATEGIES, AND MORE.BOWEL SOUNDS EPISODES ON EARLY NUTRITIONBOWEL SOUNDS IS A PODCAST ON ALL THINGS RELATED TO PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY, AND NUTRITION. EPISODES FEATURE INTERVIEWS WITH EXPERTS OFFERING CLINICAL AND ACADEMIC PEARLS AND
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt01700963
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0898647
IRS990/PYInvestmentIncomeAmt0179674
IRS990/PYOtherExpensesAmt0251386
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0645094
IRS990/PYSalariesCompEmpBnftPaidAmt085510
IRS990/PYTotalExpensesAmt01235543
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt01880637
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0483703
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt0669348
IRS990/SavingsAndTempCashInvstGrp/EOYAmt0352860
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt01904598
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt01700963
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt01387107
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt01543373
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt0756382
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt07292423
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0104663
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt092653
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt093673
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0110280
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt0108597
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0509866
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt02897232
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.44720
IRS990ScheduleA/PublicSupportPY170Pct00.60990
IRS990ScheduleA/PublicSupportTotal170Amt03488838
IRS990ScheduleA/SubstantialContributorsTotAmt03803585
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt01904598
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt01700963
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt01387107
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt01543373
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt0756382
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt07292423
IRS990ScheduleA/TotalSupportAmt07802289
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/CYEndwmtFundGrp/BeginningYearBalanceAmt02486243
IRS990ScheduleD/CYEndwmtFundGrp/EndYearBalanceAmt02058214
IRS990ScheduleD/CYEndwmtFundGrp/GrantsOrScholarshipsAmt0150000
IRS990ScheduleD/CYEndwmtFundGrp/InvestmentEarningsOrLossesAmt0-278243
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/BeginningYearBalanceAmt02472426
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/EndYearBalanceAmt02486243
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/GrantsOrScholarshipsAmt0150000
IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/InvestmentEarningsOrLossesAmt0163817
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/BeginningYearBalanceAmt02423819
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/EndYearBalanceAmt02472426
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/GrantsOrScholarshipsAmt0150000
IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/InvestmentEarningsOrLossesAmt0198607
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/BeginningYearBalanceAmt02312696
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/EndYearBalanceAmt02423819
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/GrantsOrScholarshipsAmt0150000
IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/InvestmentEarningsOrLossesAmt0261123
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/BeginningYearBalanceAmt02500000
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/EndYearBalanceAmt02312696
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/GrantsOrScholarshipsAmt099487
IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/InvestmentEarningsOrLossesAmt0-87817
IRS990ScheduleD/EndowmentsHeldRelatedOrgInd00
IRS990ScheduleD/EndowmentsHeldUnrelatedOrgInd00
IRS990ScheduleD/ExpensesNotReportedAmt00
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt023093
IRS990ScheduleD/ExpensesSubtotalAmt01488595
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/InvestmentExpensesNotIncld2Amt023093
IRS990ScheduleD/NetUnrealizedGainsInvstAmt0-560093
IRS990ScheduleD/OtherRevenueAmt0-23093
IRS990ScheduleD/PrmnntEndowmentBalanceEOYPct01.00000
IRS990ScheduleD/RevenueNotReportedAmt0-583186
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt00
IRS990ScheduleD/RevenueSubtotalAmt01995391
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0INTENDED USE OF THE ENDOWMENT FUNDS IT CONSISTS OF TWO ENDOWMENTS, BOTH WERE RECEIVED FROM PHARMACEUTICAL COMPANIES. THE INVESTMENT INCOME FOR EACH ENDOWMENT FUND IS RESTRICTED FOR THE FOLLOWING PURPOSES: [1]THE INVESTMENT INCOME FROM $1,500,000 IS RESTRICTED FOR INNOVATIVE RESEARCH AWARDS. [2]THE INVESTMENT INCOME FROM $1,000,000 IS RESTRICTED FOR RESEARCH GRANTS IN ACID-PEPTIC DISORDERS.
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt1UNCERTAIN TAX POSITIONS UNDER ASC 740 GAAP REQUIRES ENTITIES TO EVALUATE, MEASURE, RECOGNIZE AND DISCLOSE ANY UNCERTAIN INCOME TAX POSITIONS TAKEN ON THEIR TAX RETURNS. GAAP PRESCRIBES A MINIMUM RECOGNITION THRESHOLD THAT A TAX POSITION IS REQUIRED TO MEET IN ORDER TO BE RECOGNIZED IN THE FINANCIAL STATEMENTS. THE FOUNDATION BELIEVES THAT IT HAD NO UNCERTAIN TAX POSITIONS AS DEFINED IN GAAP.
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt2INVESTMENT EXPENSES -23,093.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0PART V, LINE 4:
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc1PART X, LINE 2:
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc2PART XI, LINE 2D - OTHER ADJUSTMENTS:
IRS990ScheduleD/TotalBookValueLandBuildingsAmt00
IRS990ScheduleD/TotalExpensesPerForm990Amt01511688
IRS990ScheduleD/TotalRevenuePerForm990Amt01995391
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt01412205
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt01488595
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt07746
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt1150120
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt214000
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt3643
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt4150120
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt5100120
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt675120
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt7893
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt8900
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt9150120
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/CashGrantAmt1075120

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2022 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$6,677,645
Liabilities
$1,431,689
Net assets
$5,245,956
Revenue
$1,995,391
Expenses
$1,511,688
Net income
$483,703
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$8.21$1.76$6.46$2.27$1.86$0.41
2023Detailed filing. Detailed filing data is available for this year.$7.46$1.79$5.67$1.83$1.72$0.10
2022Detailed filing. Detailed filing data is available for this year.$6.68$1.43$5.25$2.00$1.51$0.48
2021Detailed filing. Detailed filing data is available for this year.$6.52$1.20$5.32$1.88$1.24$0.65
2020Detailed filing. Detailed filing data is available for this year.$5.61$1.05$4.56$1.54$1.09$0.46
2019Detailed filing. Detailed filing data is available for this year.$4.87$0.95$3.92$1.59$1.31$0.29
2018Detailed filing. Detailed filing data is available for this year.$4.50$1.24$3.26$1.26$1.18$0.08
2017Detailed filing. Detailed filing data is available for this year.$4.42$1.01$3.41$1.07$1.18$0.11
2016Detailed filing. Detailed filing data is available for this year.$4.56$1.24$3.33$1.47$1.32$0.15
2015Detailed filing. Detailed filing data is available for this year.$4.29$1.19$3.11$1.20$1.10$0.09
2014Detailed filing. Detailed filing data is available for this year.$4.11$0.95$3.15$1.41$1.31$0.10
2013Detailed filing. Detailed filing data is available for this year.$4.07$0.99$3.08$1.38$1.25$0.13
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$4.31$1.42$2.90$1.24
2011Summary only. Only limited summary data is available for this year.$3.87$0.99$2.88$1.11$1.11$0.01
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$4.22$1.30$2.91$1.53